Adeoha Pharmaceuticals

adeona2

Adeona Starts Phase II Trials Of New MS Drug

Adeona Pharmaceuticals Inc. (NYSE Amex: AEN) said Thursday that it had started a Phase II clinical trial of Trimesta (oral estriol) for the treatment of cognitive dysfunction in multiple sclerosis in women.

WWJ Newsradio 950–01/19/2012

Follow

Get every new post delivered to your Inbox.

Join 2,062 other followers